Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance (palbociclib)
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jan 12, 2020--
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jan 12, 2020--